STAT3 and neoplasm: Interestingly, heterozygous loss of STAT3 within the tumours (Stat3ΔLep/+:KrasG12D/+) led to the same drastic phenotype as observed in Stat3ΔLep/ΔLep:KrasG12D/+ animals with a median survival of 108 days.